{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:44:31Z","timestamp":1782017071016,"version":"3.54.5"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>PCSK9-inhibitors (PCSK9i) are new drugs recently approved to lower LDL-cholesterol levels. However, due to the lack of long-term clinical data, the potential adverse effects of long-term use are still unknown. The <jats:italic>PCSK9<\/jats:italic> genetic locus has been recently implicated in mood disorders and hence we wanted to assess if the effect of PCSK9i that block the PCSK9 protein can lead to an increase in the incidence of mood disorders. We used genetically-reduced PCSK9 protein levels (pQTLs) in plasma, serum, cerebrospinal fluid as a proxy for the effect of PCSK9i. We performed Mendelian randomization analyses using PCSK9 levels as exposure and mood disorder traits major depressive disorder, mood instability, and neuroticism score as outcomes. We find no association of PCSK9 levels with mood disorder traits in serum, plasma, and cerebrospinal fluid. We can conclude that genetically proxied on-target effect of pharmacological PCSK9 inhibition is unlikely to contribute to mood disorders.<\/jats:p>","DOI":"10.1371\/journal.pone.0310396","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T17:31:58Z","timestamp":1727371918000},"page":"e0310396","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the association of the effect of genetically proxied PCSK9i with mood disorders using cis-pQTLs: A drug-target Mendelian randomization study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-5880","authenticated-orcid":true,"given":"Alisha","family":"Aman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A. W.","family":"Slob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona J.","family":"Strawbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"issue":"12","key":"pone.0310396.ref001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41569-021-00634-0","article-title":"PCSK9-targeted therapies: present and future approaches","volume":"18","author":"MA Rifai","year":"2021","journal-title":"Nature Reviews Cardiology"},{"key":"pone.0310396.ref002","first-page":"621","article-title":"Evolocumab and Alirocumab: A Review of the Emerging Role of proprotein convertase subtilisin\/Kexin Type 9 (PCSK9) Inhibitors in the Management of Hyperlipidaemia.","volume":"5","author":"W Habeichi","year":"2018","journal-title":"EC Cardiology."},{"issue":"1","key":"pone.0310396.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-019-4651-7","article-title":"Adverse drug reactions in primary care: a scoping review.","volume":"20","author":"H Khalil","year":"2020","journal-title":"BMC health services research."},{"issue":"13","key":"pone.0310396.ref004","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3390\/ijms21134725","article-title":"Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights","volume":"21","author":"U Galicia-Garcia","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"pone.0310396.ref005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1534\/genetics.117.300191","article-title":"Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer","volume":"207","author":"S Burgess","year":"2017","journal-title":"Genetics"},{"issue":"R1","key":"pone.0310396.ref006","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"G Davey Smith","year":"2014","journal-title":"Human molecular genetics"},{"issue":"5","key":"pone.0310396.ref007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","article-title":"The post-GWAS era: from association to function","volume":"102","author":"MD Gallagher","year":"2018","journal-title":"The American Journal of Human Genetics"},{"key":"pone.0310396.ref008","article-title":"Genetic analysis of the PCSK9 locus in psychological, psychiatric, metabolic and cardiovascular traits in UK Biobank.","author":"R Hay","year":"2021"},{"issue":"2","key":"pone.0310396.ref009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GMD Collaborators","year":"2022","journal-title":"The Lancet Psychiatry"},{"key":"pone.0310396.ref010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fnins.2020.00609","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in the brain and relevance for neuropsychiatric disorders.","volume":"14","author":"EM O\u2019Connell","year":"2020","journal-title":"Frontiers in neuroscience"},{"key":"pone.0310396.ref011","article-title":"PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives.","author":"SJ Nicholls","year":"2023","journal-title":"Kardiologia Polska (Polish Heart Journal)."},{"issue":"12","key":"pone.0310396.ref012","doi-asserted-by":"crossref","first-page":"e0279381","DOI":"10.1371\/journal.pone.0279381","article-title":"Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization.","volume":"17","author":"A Aman","year":"2022","journal-title":"Plos one."},{"issue":"6","key":"pone.0310396.ref013","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/hmg\/ddab279","article-title":"Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2","volume":"31","author":"J Pott","year":"2022","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"pone.0310396.ref014","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41467-021-27850-z","article-title":"A genome-wide association study of serum proteins reveals shared loci with common diseases","volume":"13","author":"A Gudjonsson","year":"2022","journal-title":"Nature communications"},{"issue":"5","key":"pone.0310396.ref015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","article-title":"Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies","volume":"54","author":"J Zhang","year":"2022","journal-title":"Nature Genetics"},{"issue":"9","key":"pone.0310396.ref016","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","article-title":"Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders","volume":"24","author":"C Yang","year":"2021","journal-title":"Nature neuroscience"},{"issue":"11","key":"pone.0310396.ref017","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/s41380-019-0439-8","article-title":"The genomic basis of mood instability: identification of 46 loci in 363,705 UK Biobank participants, genetic correlation with psychiatric disorders, and association with gene expression and function","volume":"25","author":"J Ward","year":"2020","journal-title":"Molecular psychiatry"},{"issue":"2","key":"pone.0310396.ref018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/wps.20411","article-title":"Neuroticism is a fundamental domain of personality with enormous public health implications.","volume":"16","author":"TA Widiger","year":"2017","journal-title":"World psychiatry."},{"issue":"1","key":"pone.0310396.ref019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment.","volume":"9","author":"L Cui","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"pone.0310396.ref020","first-page":"1","article-title":"Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways","volume":"9","author":"DM Howard","year":"2018","journal-title":"Nature communications"},{"key":"pone.0310396.ref021","article-title":"The MRC IEU OpenGWAS data infrastructure.","author":"B Elsworth","year":"2020","journal-title":"BioRxiv"},{"issue":"3","key":"pone.0310396.ref022","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"C Sudlow","year":"2015","journal-title":"PLoS medicine."},{"issue":"3","key":"pone.0310396.ref023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","article-title":"PCSK9 inhibitors: clinical evidence and implementation","volume":"16","author":"MS Sabatine","year":"2019","journal-title":"Nature reviews cardiology"},{"issue":"5","key":"pone.0310396.ref024","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"M-JA Brion","year":"2013","journal-title":"International journal of epidemiology"},{"issue":"12","key":"pone.0310396.ref025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ijnp\/pyy060","article-title":"Risk of neuropsychiatric adverse effects of lipid-lowering drugs: a mendelian randomization study","volume":"21","author":"J Alghamdi","year":"2018","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"pone.0310396.ref026","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mp.2016.49","article-title":"Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci","volume":"21","author":"DJ Smith","year":"2016","journal-title":"Molecular psychiatry"},{"issue":"5","key":"pone.0310396.ref027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Z Zhu","year":"2016","journal-title":"Nature genetics"},{"key":"pone.0310396.ref028","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"G Hemani","year":"2018","journal-title":"elife"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T17:32:07Z","timestamp":1727371927000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310396"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Magni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310396","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}